ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

EWTX Edgewise Therapeutics Inc

19.52
0.23 (1.19%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Edgewise Therapeutics Inc EWTX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.23 1.19% 19.52 06:30:00
개장가 저가 고가 종가 전일 종가
19.74 19.44 20.12 19.52 19.29
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
23/04/202421:00BWEdgewise Receives European Medicines Agency (EMA) Orphan..
16/04/202405:05BWEdgewise Therapeutics Announces Positive Two-Year Topline..
28/03/202421:00BWEdgewise Therapeutics Announces Upcoming Podium Presentation..
27/03/202421:00BWEdgewise Therapeutics to Present at the Cantor Virtual..
05/03/202422:00BWEdgewise Therapeutics to Present at the Leerink Partners..
28/02/202422:00BWEdgewise Therapeutics to Present on EDG-5506 for the..
22/02/202422:07EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/02/202422:00EDGAR2Form 8-K - Current report
22/02/202422:00BWEdgewise Therapeutics Reports Fourth Quarter and Full Year..
14/02/202422:43EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/02/202422:00BWEdgewise Receives U.S. FDA Fast Track Designation for..
10/02/202407:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/02/202406:15EDGAR2Form 144 - Report of proposed sale of securities
20/01/202406:54EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
19/01/202422:44EDGAR2Form 8-K - Current report
19/01/202422:37BWEdgewise Therapeutics Announces Pricing of $240 Million..
19/01/202420:05EDGAR2Form 8-K - Current report
19/01/202420:04EDGAR2Form S-3MEF - Registration adding securities to prior Form..
19/01/202420:02EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
09/01/202422:39BWEdgewise Therapeutics Highlights 2023 Accomplishments and..
29/12/202306:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202306:32EDGAR2Form 144 - Report of proposed sale of securities
19/12/202322:00BWEdgewise Therapeutics to Present at the 42nd Annual J.P...
18/12/202322:00BWEdgewise Therapeutics Launches First of Its Kind Educational..
30/11/202322:56DJNEdgewise Gets FDA Orphan, Rare-Pediatric-Disease..
30/11/202322:00BWEdgewise Receives Orphan Drug and Rare Pediatric Disease..
09/11/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:00EDGAR2Form 8-K - Current report
09/11/202322:00BWEdgewise Therapeutics Reports Third Quarter 2023 Financial..
08/11/202322:00BWEdgewise Therapeutics to Present at Upcoming Investor..
01/11/202321:00BWEdgewise to Present Data on EDG-7500 at the American Heart..
26/10/202321:00BWEdgewise Therapeutics Announces Expansion of their EDG-5506..
27/09/202321:00BWEdgewise Therapeutics to Present on EDG-5506 for Becker..
26/09/202321:00BWEdgewise Therapeutics Announces Initiation of GRAND CANYON,..
14/09/202321:00BWEdgewise Therapeutics Begins Dosing First-in-Human Phase 1..
19/08/202308:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/08/202308:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/08/202321:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/08/202321:00EDGAR2Form 8-K - Current report
10/08/202321:00BWEdgewise Therapeutics Reports Second Quarter 2023 Financial..
15/07/202305:05EDGAR2Form 8-K - Current report
27/06/202305:01BWEdgewise Therapeutics Announces Positive 12-Month Topline..
06/06/202321:00BWEdgewise Therapeutics to Present at the Goldman Sachs Global..
11/05/202321:00BWEdgewise Therapeutics Reports First Quarter 2023 Financial..

최근 히스토리

Delayed Upgrade Clock